Skip to Content

SCOR SE ADR SCRYY

Morningstar Rating
$2.28 +0.03 (1.11%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Scor Updates on Life and Health Reserving Review; Shares Undervalued

Following the negative life and health experience variance Scor incurred in the first quarter as a result of elevated levels of US mortality, Scor has issued an update for its second-quarter results for 2024. During the first quarter Scor outlined it would monitor the situation and once enough information had been gathered make a decision on the adequacy of reserves. Scor now has enough information to make a decision and has decided to accelerate its annual life and health reserve assumptions review.

Price vs Fair Value

SCRYY is trading at a 117% premium.
Price
$2.25
Fair Value
$6.60
Uncertainty
High
1-Star Price
$4.97
5-Star Price
$6.90
Economic Moat
Ykhc
Capital Allocation
Cpftwlm

Bulls Say, Bears Say

Bulls

Scor holds a significant position in the global life reinsurance market.

Bears

Controls feel a bit looser with lower-quality management and discipline within the business model.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SCRYY is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$2.25
Day Range
$2.232.28
52-Week Range
$2.123.53
Bid/Ask
$2.21 / $2.32
Market Cap
$4.08 Bil
Volume/Avg
7,246 / 24,771

Key Statistics

Price/Earnings (Normalized)
4.33
Price/Sales
2.12
Dividend Yield (Trailing)
8.66%
Dividend Yield (Forward)
8.66%
Total Yield
9.20%

Company Profile

Scor is the world’s sixth-largest reinsurer, selling nonlife and life reinsurance. Scor global life insures life insurance and annuities. This means in its co-insurance agreements Scor shares in premiums and claims of life insurance contracts that have been sold by a primary insurer. In its excess of loss agreements, Scor reimburses a primary insurer for claims that are filed above an agreed amount. Scor also sells property and casualty reinsurance in coinsurance and excess of loss. Historically, Scor has been better in specialist lines and not as good in lines where there is a large potential for loss. Having recently grown in natural catastrophe, standards of underwriting have not been good. The business has subsequently decided to move back to less volatile lines.
Sector
Financial Services
Industry
Insurance - Reinsurance
Stock Style Box
Mid Value
Total Number of Employees
3,491

Competitors

Valuation

Metric
SCRYY
SREN
MUV2
Price/Earnings (Normalized)
4.3311.3711.28
Price/Book Value
0.782.291.95
Price/Sales
2.120.740.99
Price/Cash Flow
2.1214.887.89
Price/Earnings
SCRYY
SREN
MUV2

Financial Strength

Metric
SCRYY
SREN
MUV2
Quick Ratio
Current Ratio
Interest Coverage
11.818.9823.61
Quick Ratio
No chart available

Profitability

Metric
SCRYY
SREN
MUV2
Return on Assets (Normalized)
2.38%1.83%2.04%
Return on Equity (Normalized)
17.99%23.32%19.06%
Return on Invested Capital (Normalized)
11.39%10.47%17.01%
Return on Assets
SCRYY
SREN
MUV2
See how this stock stacks up to its competitors with Morningstar Investor

Insurance - Reinsurance Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Munchener Ruckversicherungs-Gesellschaft AG
MURGF
Fgnbc$66.2 Bil
Munchener Ruckversicherungs-Gesellschaft AG ADR
MURGY
LqbpnqlxdSbstw$66.2 Bil
Swiss Re AG
SSREF
Klrm$34.7 Bil
Swiss Re AG ADR
SSREY
PhkqqbplbVxcr$34.7 Bil
Hannover Rueck SE Registered Shares
HVRRF
ZvbbdpjfLbq$30.3 Bil
Hannover Rueck SE ADR
HVRRY
XfhffwnrpTcvm$30.3 Bil
Everest Group Ltd
EG
Pjzv$16.9 Bil
Reinsurance Group of America Inc
RGA
Dxdnh$14.1 Bil
RenaissanceRe Holdings Ltd
RNR
ZpkqbjsftKvbr$11.9 Bil

Sponsor Center